News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 298508

Sunday, 06/11/2017 9:12:57 PM

Sunday, June 11, 2017 9:12:57 PM

Post# of 347009


Hmmmm....quite a coincidence or not....but this mention of "Peregrine" below was funded by Sandia


Peregrine RNA-Seq library

Peregrine
A rapid and unbiased method to produce strand-specific RNA-Seq libraries from small quantities of starting material
Stanley A. Langevin, Zachary W. Bent, [...], and Steven S. Branda

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710357/



Very interesting puzzle piece here....brings us back to Ayer Capital Management (Dr Jay Venkatesan and Pieter Boulhower ..)

July 2015 Dr Venkatesan joins Alpine

http://www.businesswire.com/news/home/20150713005408/en/Dr.-Jay-Venkatesan-Joins-Alpine-BioVentures-Managing#.VaOo8SizzDc

http://www.alpinebioventures.com/team/

Now...Alpine Biosciences acquired by Cascadian Therapeutics in August 2014 ...but read below...they licensed tech from Sandia National Labs!! ....and Sandia just had the Peregrine RNA sequence library!

We founded Alpine Biosciences in 2012 to develop "protocells", a unique nanoparticle platform technology licensed from University of Mexico and Sandia National Labs....

http://www.alpinebioventures.com/portfolio/

.....Peregrine what is it you have not been able to tell us and these are solid puzzle pieces. You telling me Dr Venkatesan with Ayer Capital mgmt....sells or forced to sell PPHM and now lands where Alpine with ties to Sandia Nation Labs that were researching Peregrine RNA proteins....??

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y